Optimising infliximab induction dosing to achieve clinical remission in Chinese patients with Crohn's disease

• 主要な著者: Kouzhu Zhu (著者), Xiaoliang Ding (著者), Ling Xue (著者), Linsheng Liu (著者), Yan Wang (著者), Yun Li (著者), Qinhua Xi (著者), Xueqin Pang (著者), Weichang Chen (著者), Liyan Miao (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

AimsA strategy based on therapeutic drug monitoring and population pharmacokinetic (popPK) models would likely increase the rate of clinical remission (CR) after infliximab (IFX) induction in patients with Crohn's disease (CD). This study aimed to evaluate the relationship between early IFX lev...